Home / Japan / OMRON Corporation
OMRON Corporation
Short position disclosed on September 2, 2026.
0.68% of the capital sold short
1 disclosing funds
12 disclosures on record
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Aug 11Aug 17Aug 23Aug 29Sep 4
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Barclays Capital Securities Ltd | 0.68% | new | September 2, 2026 |
Get the moves on OMRON Corporation by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 2, 2026 | Barclays Capital Securities Ltd | 0.68% | still open |
| September 1, 2026 | Barclays Capital Securities Ltd | 0.59% | |
| August 31, 2026 | Barclays Capital Securities Ltd | 0.68% | |
| August 28, 2026 | Barclays Capital Securities Ltd | 0.70% | |
| August 26, 2026 | Barclays Capital Securities Ltd | 0.69% | |
| August 25, 2026 | Barclays Capital Securities Ltd | 0.72% | |
| August 20, 2026 | Barclays Capital Securities Ltd | 0.68% | |
| August 14, 2026 | Barclays Capital Securities Ltd | 0.76% | |
| August 12, 2026 | Barclays Capital Securities Ltd | 0.84% | |
| August 10, 2026 | Barclays Capital Securities Ltd | 0.72% | |
| August 7, 2026 | Barclays Capital Securities Ltd | 0.87% | |
| August 5, 2026 | Goldman Sachs International | 0.40% |
Download 12 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- KLab Inc. 17.64% of the capital sold short
- Towa Corporation 14.20% of the capital sold short
- ReYuu Japan Inc. 12.56% of the capital sold short
- 3-D Matrix,Ltd. 11.82% of the capital sold short
- Sanrio Company,Ltd. 10.58% of the capital sold short
- SHIFT Inc. 10.19% of the capital sold short
- QD Laser,Inc. 10.05% of the capital sold short
- AIMECHATEC,Ltd. 9.66% of the capital sold short
- V Technology Co.,Ltd. 9.25% of the capital sold short
- Tri Chemical Laboratories Inc. 9.24% of the capital sold short
- Oncolys BioPharma Inc. 9.12% of the capital sold short
- Nissan Motor Co.,ltd. 8.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, OMRON Corporation, source JPX, data as at September 2, 2026, https://www.quivad.com/action/omron-corporation